Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.65 USD | +4.16% | -0.73% | -37.29% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Financials (USD)
Sales 2024 * | 42.96M | Sales 2025 * | 132M | Capitalization | 789M |
---|---|---|---|---|---|
Net income 2024 * | -397M | Net income 2025 * | -332M | EV / Sales 2024 * | 6.65 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 3.48 x |
P/E ratio 2024 * |
-2.01
x | P/E ratio 2025 * |
-2.51
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | -1.43% | ||
1 week | -3.61% | ||
Current month | -6.10% | ||
1 month | -24.12% | ||
3 months | -47.15% | ||
6 months | -33.08% | ||
Current year | -39.59% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 16 M€ | -4.51% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 13.59 | +3.70% | 226 994 |
24-05-02 | 13.1 | -1.32% | 914,531 |
24-05-01 | 13.28 | -4.73% | 1,516,090 |
24-04-30 | 13.94 | -1.69% | 766,141 |
24-04-29 | 14.18 | +3.58% | 864,568 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.59% | 789M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.58% | 23.07B | |
-12.60% | 22.23B | |
-7.42% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- SAGE Stock